ORG Wealth Partners’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.76K Buy
+85
New +$1.99K ﹤0.01% 1437

Other funds holding DNLI

ORG Wealth Partners's DNLI Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Denali Therapeutics (DNLI) in Q3 2026: 85 shares worth $1.76K. The stake represents ﹤0.01% of the portfolio and ranks #1437 among its holdings.

287 funds tracked by Wall St. Rank hold DNLI as of Q3 2026.

  • ORG Wealth Partners held 85 shares of Denali Therapeutics worth $1.76K as of Q3 2026.
  • Denali Therapeutics was a new ORG Wealth Partners position in Q3 2026.
  • Denali Therapeutics made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #1437 holding.
  • 287 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.